|
End-of-day quote
Buenos Aires S.E.
02/11/2026
|
5-day change | 1st Jan Change | ||
| 136.00 ARS | -1.81% |
|
+0.37% | -43.45% |
| Market Cap | 579.22Cr 37.52L 33.49L 30.74L 27.96L 52.42L 36Cr 53.46L 3.67Cr 1.48Cr 19Cr 1.41Cr 1.38Cr 59Cr | P/E 2024 |
-3.67x | P/E 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 652.99Cr 42.29L 37.76L 34.65L 31.52L 59.1L 40Cr 60.27L 4.14Cr 1.67Cr 21Cr 1.59Cr 1.55Cr 67Cr | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.81% | ||
| 1 week | +0.37% | ||
| Current month | -1.81% | ||
| 1 month | -3.20% | ||
| 3 months | -14.73% | ||
| 6 months | -17.58% | ||
| Current year | -43.45% |
| 1 week | 130 |  | 144 |
| 1 month | 130 | | 154 |
| Current year | 128.5 | | 260 |
| 1 year | 128.5 | | 357 |
| 3 years | 46 | | 450 |
| 5 years | 9.1 | | 450 |
| 10 years | 4.2 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 30/07/2010 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/07/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.81% | +0.37% | -15.53% | +183.92% | 37.52L | |
| -0.46% | +10.31% | +63.52% | +143.15% | 1,25700Cr | |
| -0.97% | +1.60% | +43.25% | +80.09% | 65TCr | |
| -2.05% | +0.73% | +32.47% | +101.62% | 51TCr | |
| -0.24% | -0.85% | +52.45% | +66.74% | 39TCr | |
| -0.78% | +5.51% | +72.55% | +44.25% | 37TCr | |
| +0.71% | +2.98% | +33.29% | +59.13% | 30TCr | |
| -0.12% | +7.99% | +11.99% | +34.82% | 29TCr | |
| -0.12% | +4.68% | +55.97% | +74.59% | 25TCr | |
| -0.21% | +7.34% | +42.19% | +109.69% | 21TCr | |
| Average | -0.36% | +4.10% | +39.21% | +89.80% | 42.27TCr | |
| Weighted average by Cap. | -0.31% | +5.30% | +49.21% | +93.67% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 827.49Cr 53.6L 47.85L 43.91L 39.94L 74.89L 51Cr 76.38L 5.24Cr 2.11Cr 27Cr 2.01Cr 1.97Cr 85Cr | 640.36Cr 41.48L 37.03L 33.98L 30.91L 57.95L 39Cr 59.11L 4.06Cr 1.64Cr 21Cr 1.56Cr 1.52Cr 65Cr |
| Net income | -141.73Cr -9L -8L -8L -7L -12.83L -8.69Cr -13.08L -89.83L -36.21L -4.59Cr -34.45L -33.72L -14Cr | -459.77Cr -29.78L -26.59L -24.4L -22.19L -41.61L -28Cr -42.44L -2.91Cr -1.17Cr -15Cr -1.12Cr -1.09Cr -47Cr |
| Net Debt | 86Cr 6L 5L 5L 4L 8L 5.29Cr 8L 54.71L 22.05L 2.79Cr 20.98L 20.54L 8.82Cr | 74Cr 5L 4L 4L 4L 7L 4.52Cr 7L 46.76L 18.85L 2.39Cr 17.93L 17.55L 7.54Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | ARS 136.00 | -1.81% | 3,263 |
| 30/26/30 | ARS 138.50 | -0.72% | 10,354 |
| 29/26/29 | ARS 139.50 | +2.57% | 1,200 |
| 28/26/28 | ARS 136.00 | -0.37% | 10,969 |
| 27/26/27 | ARS 136.50 | +0.74% | 17,143 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
